TransCode Therapeutics Inc (NASDAQ: RNAZ) Could See A Rise In Prices Shortly.

In the last trading session, 1.17 million shares of the TransCode Therapeutics Inc (NASDAQ:RNAZ) were traded, and its beta was 1.15. Most recently the company’s share price was $1.92, and it changed around -$0.06 or -3.03% from the last close, which brings the market valuation of the company to $1.34M. RNAZ currently trades at a discount to its 52-week high of $66.33, offering almost -3354.69% off that amount. The share price’s 52-week low was $1.89, which indicates that the current value has risen by an impressive 1.56% since then.

TransCode Therapeutics Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended RNAZ as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. TransCode Therapeutics Inc is expected to report earnings per share of -3.21 for the current quarter.

TransCode Therapeutics Inc (NASDAQ:RNAZ) trade information

Instantly RNAZ has showed a red trend with a performance of -3.03% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 6.8500 on recent trading dayincreased the stock’s daily price by 71.97%. The company’s shares are currently down -43.03% year-to-date, but still down -71.68% over the last five days. On the other hand, TransCode Therapeutics Inc (NASDAQ:RNAZ) is -76.15% down in the 30-day period.

Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 300k in revenue for the current quarter. Forecasts for the next quarter put sales growth at 0.00%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -28.81%. TransCode Therapeutics Inc earnings are expected to increase by 95.41% in 2025, but the outlook is positive 78.85% per year for the next five years.